Cancer Pharmacogenomics Development, Science, Translation

More documents

Recommendations

Info

Tamoxifen Pharmacogenetics Breast Cancer (190 Patients) Relapse–Free Survival, % Disease–Free Survival Goetz et al., Breast Cancer Res. Treat. 2007; 101:113-121. Reprinted by permission of Springer Science+Business Media.
Tamoxifen Pharmacogenetics No Tamoxifen Tamoxifen Tamoxifen Schroth et al., JCO. 2007; 25:5187-93. Reprinted with permission. © 2010 American Society of Clinical Oncology. All rights reserved.
Page 1 and 2: Cancer Pharmacogenomics Development
Page 3 and 4: Pharmacogenetics-Pharmacogenomics C
Page 5 and 6: Pharmacogenetics-Pharmacogenomics S
Page 7 and 8: Pharmacogenetics-Pharmacogenomics F
Page 9 and 10: • Low TPMT TPMT Genetic Polymorph
Page 11 and 12: Pharmacogenetics-Pharmacogenomics F
Page 13: CYP2D6 Pharmacogenetics Number of S
Page 17 and 18: Cancer Pharmacogenomics • Introdu
Page 19 and 20: Cytidine Analogues Ara-C N NH 2 Gem
Page 21 and 22: Gemcitabine-AraC IC50 - Expression
Page 23 and 24: The Therapeutic Revolution Goodman
Page 25 and 26: FKBP5 Functional Characterizatoin C
Page 27 and 28: Pharmacogenomics Genomic Era Develo
Page 29 and 30: Cancer Pharmacogenomics Challenges
Page 32: Mayo Pharmacogenomics Laboratories

Cancer Pharmacogenomics Development, Science, Translation

Create successful ePaper yourself

Delete template?

Save as template?